Definium Therapeutics to Host Investor and Analyst Day in New York on April 22, 2026
News Source : Financial Post
News Summary
- Definium Therapeutics, Inc. (NASDAQ: DFTX) announces additional details for its Investor & Analyst Day in New York on April 22, 2026.
- Presentations and live question and answer sessions will be led by members of the executive leadership team and external key opinion leaders.
- Key areas of discussion will include DT120 ODT (lysergide tartrate), Definium’s lead investigational program in Phase 3 development for GAD and MDD.
NEW YORK Definium Therapeutics, Inc. (NASDAQ DFTX), a latestage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric a [+4967 chars]
Never miss a story from us, subscribe to our newsletter